Point of Care Diagnostics Market
Point of Care Diagnostics Market - Global Industry Assessment & Forecast
#
Pages:
146
Base Year:
2022
Aug - 2022
Format:
Report Code:
VMR-1821
Segments Covered
By
Product Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuse (DOA) Testing, Urinalysis/Nephrology
-
By
End Users Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratories
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 45.06 Billion |
 Revenue 2030:
|
USD 95.89 Billion |
 Revenue CAGR
(2023 - 2030): |
9.90% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Point of Care Diagnostics Market Segment Analysis
- Point of Care Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Point of Care Diagnostics End Users Outlook (Revenue, USD Million, 2018 - 2030)
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
-
North America Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- U.S.
- U.S. Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- U.S. Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- U.S. Point of Care Diagnostics Market, by Product
- Canada
- Canada Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Canada Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Canada Point of Care Diagnostics Market, by Product
-
Mexico
- Mexico Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Mexico Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Mexico Point of Care Diagnostics Market, by Product
-
North America Point of Care Diagnostics Market, by Product
- Europe
-
Europe Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
-
Europe Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- U. K.
- U.K. Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- U.K. Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- U.K. Point of Care Diagnostics Market, by Product
- France
- France Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- France Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- France Point of Care Diagnostics Market, by Product
-
Germany
- Germany Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Germany Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Germany Point of Care Diagnostics Market, by Product
-
Italy
- Italy Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Italy Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Italy Point of Care Diagnostics Market, by Product
-
Spain
- Spain Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Spain Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Spain Point of Care Diagnostics Market, by Product
-
Rest of Europe
- Rest of Europe Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Rest of Europe Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Rest of Europe Point of Care Diagnostics Market, by Product
-
Europe Point of Care Diagnostics Market, by Product
- Asia Pacific
-
Asia Pacific Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
-
Asia Pacific Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- China
- China Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- China Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- China Point of Care Diagnostics Market, by Product
- Japan
- Japan Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Japan Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Japan Point of Care Diagnostics Market, by Product
-
Germany
- Germany Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Germany Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Germany Point of Care Diagnostics Market, by Product
-
India
- India Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- India Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- India Point of Care Diagnostics Market, by Product
-
South Korea
- South Korea Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- South Korea Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- South Korea Point of Care Diagnostics Market, by Product
-
South East Asia
- South East Asia Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- South East Asia Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- South East Asia Point of Care Diagnostics Market, by Product
-
Rest of Asia Pacific
- Rest of Asia Pacific Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Rest of Asia Pacific Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Rest of Asia Pacific Point of Care Diagnostics Market, by Product
-
Asia Pacific Point of Care Diagnostics Market, by Product
- Latin America
-
Latin America Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
-
Latin America Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Brazil
- Brazil Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Brazil Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Brazil Point of Care Diagnostics Market, by Product
- Argentina
- Argentina Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Argentina Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Argentina Point of Care Diagnostics Market, by Product
-
Rest of Latin America
- Rest of Latin America Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Rest of Latin America Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Rest of Latin America Point of Care Diagnostics Market, by Product
-
Latin America Point of Care Diagnostics Market, by Product
- Middle East & Africa
-
Middle East & Africa Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
-
Middle East & Africa Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- GCC Countries
- GCC Countries Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- GCC Countries Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- GCC Countries Point of Care Diagnostics Market, by Product
- South Africa
- South Africa Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- South Africa Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- South Africa Point of Care Diagnostics Market, by Product
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Point of Care Diagnostics Market, by Product
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Urinalysis/Nephrology
- Rest of Middle East & Africa Point of Care Diagnostics Market, by End Users
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Rest of Middle East & Africa Point of Care Diagnostics Market, by Product
-
Middle East & Africa Point of Care Diagnostics Market, by Product
- North America
Vantage Market
Research | 01-Sep-2022
FAQ
Frequently Asked Question
What is the global demand for Point of Care Diagnostics in terms of revenue?
-
The global Point of Care Diagnostics valued at USD 45.06 Billion in 2022 and is expected to reach USD 95.89 Billion in 2030 growing at a CAGR of 9.90%.
Which are the prominent players in the market?
-
The prominent players in the market are F. Hoffmann-La Roche Ltd., Qiagen, Danaher Corp., Becton Dickinson (BD), Biomerieux SA, Abbott Laboratories, Siemens Healthcare AG, Zoetis Inc., Instrumentation Laboratory, Nova Biomedical, Trividia Health Inc., Quidel Corp., Trinity Biotech, Sekisui Diagnostics, Orasure Technologies Inc., Nipro Corp., Spectral Medical Inc..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 9.90% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Point of Care Diagnostics include
- High prevalence of infectious diseases
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Point of Care Diagnostics in 2022.
